论文信息 - Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor. - 字舞流文

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor.

R. Sims | R. Cummings | F. Poy | Annissa J Huhn | Chirag H. Patel | A. Gardberg | Julian R. Levell | Jonathan E. Wilson | Gaurav Patel | F. Brucelle | Nico R. Cantone | A. Bommi-Reddy